Sinnige Judith, Braspenning Jozé C, Schellevis François G, Hek Karin, Stirbu Irina, Westert Gert P, Korevaar Joke C
NIVEL, Netherlands Institute for Health Services Research, Utrecht, The Netherlands.
Radboud University Medical Center, Radboud Institute for Health Sciences, IQ Healthcare, Nijmegen, The Netherlands.
Pharmacoepidemiol Drug Saf. 2016 Sep;25(9):1033-41. doi: 10.1002/pds.4016. Epub 2016 May 2.
Complex medication management in older people with multiple chronic conditions can introduce practice variation in polypharmacy prevalence. This study aimed to determine the inter-practice variation in polypharmacy prevalence and examine how this variation was influenced by patient and practice characteristics.
This cohort study included 45,731 patients aged 55 years and older with at least one prescribed medication from 126 general practices that participated in NIVEL Primary Care Database in the Netherlands. Medication dispensing data of the year 2012 were used to determine polypharmacy. Polypharmacy was defined as the chronic and simultaneous use of at least five different medications. Multilevel logistic regression models were constructed to quantify the polypharmacy prevalence variation between practices. Patient characteristics (age, gender, socioeconomic status, number, and type of chronic conditions) and practice characteristics (practice location and practice population) were added to the models.
After accounting for differences in patient and practice characteristics, polypharmacy rates varied with a factor of 2.4 between practices (from 12.4% to 30.1%) and an overall mean of 19.8%. Age and type of conditions were highly positively associated with polypharmacy, and to a lesser extent a lower socioeconomic status.
Considerable variation in polypharmacy rates existed between general practices, even after accounting for patient and practice characteristics, which suggests that there is not much agreement concerning medication management in this complex patient group. Initiatives that could reduce inappropriate heterogeneity in medication management can add value to the care delivered to these patients. Copyright © 2016 John Wiley & Sons, Ltd.
患有多种慢性病的老年人复杂药物管理可能会导致多药合用流行率出现实践差异。本研究旨在确定多药合用流行率的实践间差异,并探讨这种差异如何受到患者和实践特征的影响。
这项队列研究纳入了45731名年龄在55岁及以上、来自荷兰参与NIVEL初级保健数据库的126家全科诊所且至少服用一种处方药的患者。使用2012年的药物配药数据来确定多药合用情况。多药合用被定义为慢性且同时使用至少五种不同药物。构建多水平逻辑回归模型以量化各诊所间多药合用流行率的差异。将患者特征(年龄、性别、社会经济地位、慢性病数量和类型)和实践特征(诊所位置和诊所人群)纳入模型。
在考虑患者和实践特征的差异后,各诊所间的多药合用率相差2.4倍(从12.4%到30.1%),总体平均为19.8%。年龄和疾病类型与多药合用高度正相关,社会经济地位较低的相关性较小。
即使考虑了患者和实践特征,全科诊所之间的多药合用率仍存在相当大的差异,这表明在这个复杂患者群体的药物管理方面没有太多共识。能够减少药物管理中不适当异质性的举措可以为这些患者提供的护理增加价值。版权所有©2016约翰威立父子有限公司。